Nerre Therapeutics Limited
Records under this name other than the patents Nerre Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Nerre Therapeutics Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,093,242 | Crystalline Forms of a Pyridine Derivative Formerly held In force · High confidence | In force | High confidence | |
| US 8,796,269 | Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,195,205 | Uses of Dual NK1/NK3 Receptor Antagonists for Treating Sex-Hormone Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 10,774,091 | Soft Gelatin Capsule Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 11,767,328 | Method of Treatment of Symptoms of Menopause Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,787,820 | Method of Treating Certain Sex Hormone-Dependent Diseases Administering a Soft Gelatin Capsule Comprising NK1 and NK3 Receptors Antagonists Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,264,164 | Method of Treatment of Symptoms of Menopause Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,591,346 | Method of Treatment of Symptoms of Menopause Formerly held In force · High confidence | In force | High confidence | |
| US 7,683,056 | Pyridine Derivatives and Their Use in the Treatment of Psychotic Disorders Formerly held Term ended Term ended Sep 15, 2026 · High confidence | Term ended | Term ended Sep 15, 2026 | High confidence |
| US 7,919,491 | Pyridine derivatives and their use in the treatment of psychotic disorders Formerly held Term ended Term ended Sep 7, 2026 · From the USPTO record | Term ended | Term ended Sep 7, 2026 | From the USPTO record |